Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-κB activation and interleukin-8 expression in gastric epithelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 345-352

  Shimada, Tadahito ^a   Watanabe, Naomi ^a   Ohtsuka, Yukio ^a   Endoh, Motoya ^a   Kojima, Kazuo ^a   Hiraishi, Hideyuki ^a   Terano, Akira ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; PHORBOL ESTER; POLAPREZINC; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; STOMACH EPITHELIUM;

ANTI-ULCER AGENTS; CARNOSINE; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; NF-KAPPA B; ORGANOMETALLIC COMPOUNDS; PHOSPHORYLATION; RNA, MESSENGER; STOMACH; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032825029     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N and Matsushima K (1997) Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 65:3218-3224.
2. Alcala-Santaella H, Castellanos D, Velo JL and Gonzalez-Lara V (1985) Zinc acexamate in treatment of duodenal ulcer. Lancet 2:157.
3. 2. Dig Dis Sci 85:559-566.
4. Baeuerle PA and Baltimore D (1996) NF-κB: Ten years after. Cell 87:13-20.
5. Baeuerle PA and Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
6. Brown K, Geerstberger S, Carlson L, Franzoso G and Siebenlist U (1995) Control of IκB-α proteolysis by site-specific signal-induced phosphorylation. Science (Wash DC) 267:1485-1488.
7. Cho CH, Luk CT and Ogle CW (1991) The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. Life Sci 49:169-194.
8. Cho CH and Ogle CW (1977) The effects of zinc sulphate on vagal-induced mast cell changes and ulcers in the rat stomach. Eur J Pharmacol 48:315-322.
9. Cho CH and Ogle CW (1978) A correlative study of the antiulcer effects of zinc sulphate in stressed rats. Eur J Pharmacol 48:97-105.
10. Cho CH, Ogle CW and Dai S (1976) Effects of zinc chloride on gastric secretion and ulcer formation in pylorus-occluded rats. Eur J Pharmacol 88:337-341.
11. Crabtree JE (1996) Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10 (Suppl 1):29-37.
12. Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichel P and Tomplins DS (1994) CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 47:945-950.
13. Connell P, Young VM, Toborek M, Cohen DA, Barve S, McClain CJ and Hennig B (1997) Zinc attenuates tumor necrosis factor-mediated activation of transcription factors in endothelial cells. JAm Coll Nutr 16:411-417.
14. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature (Lond) 388:548-554.
15. Frommer DJ (1985) The healing of gastric ulcers by zinc sulphate. Med J Austr 2:793-795.
16. Gilmore TD, Koedood M, Piffat KA and White DW (1996) Rel/NF-κB/IκB proteins and cancer. Oncogene 13:1367-1378.
17. Harada A, Mukaida N and Matsushima K (1996) Interleukin-8 as a novel target for intervention therapy in acute inflammatory diseases. Mol Med Today 2:482-489.
18. Hiraishi H, Sasai T, Oinuma T, Shimada T, Sugaya H and Terano A (1999) Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro. Alim Pharmacol Ther 1999 13:261-269.
19. Keates S, Hitti YS, Upton M and Kelly CP (1997) Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 113:1099-1109.
20. Matsusaka T, Fujikawa K, Nishio Y, Mukaida M, Matsushima K, Kishimoto T and Akira S (1993) Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10193-10197.
21. Morise K, Oka Y, Suzuki T, Kusuhara K, Iwase H and Maeda Y (1992) Clinical effect of Z-103 in the treatment of gastric ulcer. Jpn Pharmacol Ther 20:235-244.
22. Motoyama T, Hojo H and Watanabe H (1986) Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36:65-83.
23. Mukaida N, Mahe Y and Matsushima K (1990) Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 34:21128-21133.
24. Nagai K, Suda T, Kawasaki K and Matsuura S. (1986) Action of carnosine and β-leanne on wound healing. Surgery 100:815-821.
25. Neurath MF, Pettersson S, Buschenfelde KHM and Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Med 2:998-1004.
26. Papavassiliou AG (1998) Transcription-factor-modulating agents: Precision and selectivity in drug design. Mol Med Today 4:358-366.
27. Schreiber E, Matthias P, Müller MM and Shaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acid Res 17:6419.
28. Seiki M, Aita H, Mera Y, Arai K, Toyama S, Furuta S, Morita H, Hori Y, Yoneta T and Tagashira E (1992) The gastric mucosal adhesiveness of Z-103 in rats with chronic ulcer. Folia Pharmacol Jpn 99:255-263.
29. Sen CK and Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720.
30. Sharma HW and Narayanan R(1996) The NF-κB transcription factor in oncogenesis. Anticancer Res 16:589-596.
31. Shimada T and Terano A (1998) Chemokine expression in Helicobacter pylori-infected gastric mucosa. J Gastroenterol 33:613-617.
32. Shimada T, Watanabe N, Hiraishi H and Terano A (1999) Redox regulation of IL-8 expression in MKN28 cells. Dig Dis Sci 44:266-273.
33. Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN, Wilk S and Baeuerle PA (1995) Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14:2876-2883.
34. Ueki S, Seiki M, Yoneta T, Omata T, Hori Y, Ishikawa M and Tagashira E (1989) Effect of Z-103 on compound 48/80-induced gastric lesions in rats. Scand J Gastroenterol 24 (Suppl 162):202-205.
35. Varas-Lorenzo MJ (1986) Zinc acexamate and ranitidine in the short- and mid-term management of gastroduodenal ulcers. Curr Ther Res 39:19-29.
36. Vizioli MR and Almeida OP (1978) Effects of carnosine on the development of rat sponge-induced granulation. I. General morphology and glycosaminoglycans histophotometry. Cell Mol Biol 23:267-273.
37. Yamakawa A (1975) Effect of L-carnosine (N-2-M) on experimental gastric ulcer Showa Med J 38:113-126.
38. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M and Matsuahima K (1992) Tumor necrosis factor a and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 31:22506-22511.
39. Yoshikawa T, Naito Y, Tanigawa T and Yoneta T (1991a) The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-amonopropionyl)-L-histidinato zinc. Biochim Biophys Acta 1115:115-122.
40. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Yasuda M, Ueda S, Oyamada H and Kondo M (1991b) Effect of zinc-carnosine chelate compound (Z-103), a novel anti-oxidant, on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Free Rad Res Comms 14:289-296.